Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Mar-24 4:15 PM View:  | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 25-Mar-24 | Sale (Planned) | 17,435 | $35.02 | $610,574.00 | (4%) 490.88K to 473.45K | |
| 21-Mar-24 5:27 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 19-Mar-24 | Sale (Planned) | 8,565 | $35.01 | $299,839.00 | (2%) 499.45K to 490.88K | |
| 03-Nov-23 4:30 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Nov-23 | Sale (Planned) | 5,000 | $18.72 | $93,601.50 | (< 1%) 504.45K to 499.45K | |
| 04-Oct-23 4:06 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 02-Oct-23 | Sale (Planned) | 5,000 | $25.61 | $128,062.00 | (< 1%) 509.45K to 504.45K | |
| 05-Sep-23 4:05 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Sep-23 | Sale (Planned) | 5,000 | $31.45 | $157,264.00 | (< 1%) 514.45K to 509.45K | |
| 17-Aug-23 5:00 PM View: | Sassine Andy Chief Financial Officer Director | Arcturus Therapeutics Holdi... (ARCT) | 15-Aug-23 | Grant | 1,223 | $17.37 | $21,248.40 | < 1% 269.3K to 270.53K | |
| 03-Aug-23 4:15 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Aug-23 | Sale (Planned) | 5,000 | $34.91 | $174,550.00 | (< 1%) 519.45K to 514.45K | |
| 18-Jul-23 6:50 PM View: | Kummerfeld Keith C See Remarks | Arcturus Therapeutics Holdi... (ARCT) | 14-Jul-23 | Option Exercise | 6,968 | $8.96 | $62,408.40 | 733% 0.95K to 7.92K | |
| 18-Jul-23 6:50 PM View: | Kummerfeld Keith C See Remarks | Arcturus Therapeutics Holdi... (ARCT) | 14-Jul-23 | Planned Option Sale | 6,968 | $35.00 | $243,880.00 | (88%) 7.92K to 0.95K | |
| 18-Jul-23 6:50 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 14-Jul-23 | Sale (Planned) | 25,000 | $35.01 | $875,250.00 | (5%) 544.45K to 519.45K | |
| 07-Jul-23 6:01 AM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 03-Jul-23 | Sale (Planned) | 5,000 | $28.75 | $143,750.00 | (< 1%) 549.45K to 544.45K | |
| 05-Jun-23 4:07 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Jun-23 | Sale (Planned) | 5,000 | $27.16 | $135,800.00 | (< 1%) 554.45K to 549.45K | |
| 12-May-23 4:05 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 11-May-23 | Sale (Planned) | 7,925 | $30.24 | $239,652.00 | (1%) 562.37K to 554.45K | |
| 12-May-23 4:05 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 10-May-23 | Sale (Planned) | 17,075 | $30.00 | $512,250.00 | (3%) 579.45K to 562.37K | |
| 03-May-23 4:08 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-May-23 | Sale (Planned) | 5,000 | $25.93 | $129,650.00 | (< 1%) 584.45K to 579.45K | |
| 19-Apr-23 4:57 PM View: | Kummerfeld Keith C See Remarks | Arcturus Therapeutics Holdi... (ARCT) | 18-Apr-23 | Option Exercise | 6,968 | $8.96 | $62,408.30 | 733% 0.95K to 7.92K | |
| 19-Apr-23 4:57 PM View: | Kummerfeld Keith C See Remarks | Arcturus Therapeutics Holdi... (ARCT) | 18-Apr-23 | Planned Option Sale | 6,968 | $28.18 | $196,358.00 | (88%) 7.92K to 0.95K | |
| 05-Apr-23 8:47 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 03-Apr-23 | Sale (Planned) | 5,000 | $25.38 | $126,900.00 | (< 1%) 589.45K to 584.45K | |
| 08-Mar-23 9:34 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 06-Mar-23 | Sale (Planned) | 5,000 | $16.07 | $80,350.00 | (< 1%) 594.45K to 589.45K | |
| 19-Dec-22 5:02 PM View: | Marquet Magda Director | Arcturus Therapeutics Holdi... (ARCT) | 15-Dec-22 | Purchase | 2,222 | $18.00 | $39,996.00 | 10% 22.72K to 24.94K | |
| 28-Nov-22 4:07 PM View: | Payne Joseph E President and CEO Director | Arcturus Therapeutics Holdi... (ARCT) | 23-Nov-22 | Purchase | 5,000 | $16.51 | $82,550.00 | < 1% 1.48M to 1.48M | |
| 17-Aug-22 4:05 PM View: | Sassine Andy Chief Financial Officer Director | Arcturus Therapeutics Holdi... (ARCT) | 15-Aug-22 | Grant | 1,068 | $18.42 | $19,672.00 | < 1% 268.24K to 269.3K | |
| 06-Jan-22 4:01 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 04-Jan-22 | Sale (Planned) | 8,100 | $40.00 | $324,000.00 | (1%) 602.55K to 594.45K | |
| 20-Dec-21 4:01 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 16-Dec-21 | Sale (Planned) | 3,633 | $40.00 | $145,328.00 | (< 1%) 606.18K to 602.55K | |
| 10-Dec-21 4:01 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 08-Dec-21 | Sale (Planned) | 6,367 | $40.00 | $254,680.00 | (1%) 612.55K to 606.18K | |
| 03-Nov-21 11:20 AM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Nov-21 | Sale (Planned) | 10,000 | $44.41 | $444,100.00 | (2%) 622.55K to 612.55K | |
| 04-Oct-21 5:01 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Oct-21 | Sale (Planned) | 10,000 | $44.36 | $443,600.00 | (2%) 632.55K to 622.55K | |
| 02-Sep-21 9:06 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Sep-21 | Sale (Planned) | 10,000 | $55.86 | $558,600.00 | (2%) 642.55K to 632.55K | |
| 12-Aug-21 5:11 PM View: | Ultragenyx Pharmaceutical I... Director | Arcturus Therapeutics Holdi... (ARCT) | 11-Aug-21 | Sale | 75,000 | $45.83 | $3,437,250.00 | (5%) 1.48M to 1.4M | |
| 12-Aug-21 5:11 PM View: | Ultragenyx Pharmaceutical I... Director | Arcturus Therapeutics Holdi... (ARCT) | 10-Aug-21 | Sale | 725,000 | $55.44 | $40,194,000.00 | (33%) 2.2M to 1.48M | |
| 05-Aug-21 4:32 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 03-Aug-21 | Sale (Planned) | 10,000 | $40.07 | $400,700.00 | (2%) 652.55K to 642.55K | |
| 05-Apr-21 4:30 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Apr-21 | Sale (Planned) | 10,000 | $42.95 | $429,500.00 | (2%) 662.55K to 652.55K | |
| 03-Mar-21 10:00 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Mar-21 | Sale (Planned) | 10,000 | $54.23 | $542,300.00 | (1%) 672.55K to 662.55K | |
| 03-Feb-21 4:45 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Feb-21 | Sale (Planned) | 10,000 | $75.31 | $753,100.00 | (1%) 682.55K to 672.55K | |
| 05-Jan-21 6:19 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 04-Jan-21 | Sale (Planned) | 10,000 | $46.40 | $464,000.00 | (1%) 692.55K to 682.55K | |
| 10-Dec-20 4:55 PM View: | Ultragenyx Pharmaceutical I... Director 10% Owner | Arcturus Therapeutics Holdi... (ARCT) | 09-Dec-20 | Sale | 357,745 | $94.97 | $33,975,000.00 | (14%) 2.56M to 2.2M | |
| 10-Dec-20 4:55 PM View: | Ultragenyx Pharmaceutical I... Director 10% Owner | Arcturus Therapeutics Holdi... (ARCT) | 08-Dec-20 | Sale | 442,255 | $105.54 | $46,675,600.00 | (15%) 3.0M to 2.56M | |
| 03-Dec-20 5:45 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Dec-20 | Sale | 10,000 | $96.19 | $961,900.00 | (1%) 702.55K to 692.55K | |
| 03-Nov-20 8:01 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 02-Nov-20 | Sale | 10,000 | $55.28 | $552,800.00 | (1%) 712.55K to 702.55K | |
| 02-Oct-20 5:00 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 01-Oct-20 | Sale | 10,000 | $42.83 | $428,300.00 | (1%) 722.55K to 712.55K | |
| 04-Sep-20 5:05 PM View: | Chivukula Pad Chief Scientific Officer & COO | Arcturus Therapeutics Holdi... (ARCT) | 03-Sep-20 | Sale | 10,000 | $45.16 | $451,600.00 | (1%) 732.55K to 722.55K | |
| 12-Jun-20 6:22 PM View: | Kummerfeld Keith C See Remarks | Arcturus Therapeutics Holdi... (ARCT) | 12-Jun-20 | Purchase | 450 | $33.33 | $14,998.50 | 90% 0.5K to 0.95K | |
| 10-Jun-20 9:59 PM View: | Sassine Andy Chief Financial Officer Director | Arcturus Therapeutics Holdi... (ARCT) | 10-Jun-20 | Purchase | 5,000 | $29.74 | $148,700.00 | 2% 268.25K to 273.25K | |
| 10-Jun-20 9:59 PM View: | Payne Joseph E President and CEO Director | Arcturus Therapeutics Holdi... (ARCT) | 10-Jun-20 | Purchase | 1,000 | $31.69 | $31,690.00 | < 1% 1.47M to 1.48M | |
| 22-May-20 1:41 PM View: | Ultragenyx Pharmaceutical I... Director 10% Owner | Arcturus Therapeutics Holdi... (ARCT) | 20-May-20 | Option Exercise | 600,000 | $16.00 | $9,600,000.00 | 25% 2.4M to 3.0M | |
| 09-Dec-19 9:45 PM View: | Sassine Andy Chief Financial Officer Director | Arcturus Therapeutics Holdi... (ARCT) | 05-Dec-19 | Purchase | 5,649 | $9.73 | $54,964.80 | 2% 262.6K to 268.25K | |
| 05-Dec-19 9:39 PM View: | Sassine Andy Chief Financial Officer Director | Arcturus Therapeutics Holdi... (ARCT) | 03-Dec-19 | Purchase | 10,000 | $10.00 | $100,000.00 | 4% 247.6K to 257.6K | |
| 17-Sep-19 9:37 PM View: | Marquet Magda Director | Arcturus Therapeutics Holdi... (ARCT) | 13-Sep-19 | Purchase | 2,300 | $10.58 | $24,334.00 | 11% 20.42K to 22.72K | |
| 12-Sep-19 9:00 PM View: | Kummerfeld Keith C See Remarks | Arcturus Therapeutics Holdi... (ARCT) | 12-Sep-19 | Purchase | 500 | $10.69 | $5,346.70 | 100% 0 to 0.5K | |
| 30-Aug-19 5:00 PM View: | Payne Joseph E President and CEO Director 10% Owner | Arcturus Therapeutics Holdi... (ARCT) | 29-Aug-19 | Purchase | 5,000 | $11.22 | $56,100.00 | < 1% 1.47M to 1.47M |
